Page last updated: 2024-11-12

js399-19

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phenamacril: an effective agent against several fungi species belonging to the Fusarium genus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10632495
SCHEMBL ID230664
MeSH IDM0534964

Synonyms (12)

Synonym
39491-78-6
SCHEMBL230664
phenamacril
2-propenoic acid, 3-amino-2-cyano-3-phenyl-, ethyl ester, (2z)-; 2-propenoic acid, 3-amino-2-cyano-3-phenyl-, ethyl ester, (z)- (9ci); ethyl (2z)-3-amino-2-cyano-3-phenylprop-2-enoate; ethyl (z)-3-amino-2-cyano-3-phenylprop-2-enoate; phenamacril; phenamac
ethyl (z)-3-amino-2-cyano-3-phenylprop-2-enoate
js399-19
ethyl (z)-3-amino-2-cyano-3-phenylacrylate
q8v ,
ethyl (2z)-3-amino-2-cyano-3-phenylprop-2-enoate
3-amino-2-cyano-3-phenyl-2-propenoic acid ethyl ester
(z)-ethyl 3-amino-2-cyano-3-phenylacrylate
AKOS040745904
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (21.43)24.3611
2020's11 (78.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]